**Question:** Necrobiosis lipoidica is seen in -

A. Diabetes mellitus
B. Systemic lupus erythematosus
C. Scleroderma
D. Skin infections

**Core Concept:** Necrobiosis lipoidica is a rare granulomatous dermatosis characterized by lipoid inflammation and fibrosis of the dermis. It is typically seen in patients with underlying systemic disorders.

**Why the Correct Answer is Right:** Necrobiosis lipoidica is primarily associated with diabetes mellitus (option A). The condition presents as a symmetrical, indurated plaque with a characteristic "target-like" appearance. The involvement of lipoid inflammation and fibrosis in necrobiosis lipoidica suggests a relationship with diabetes, which is a known complication of long-standing diabetes mellitus.

**Why Each Wrong Option is Incorrect:**

A. Systemic lupus erythematosus (option B) is an autoimmune disorder characterized by inflammation of connective tissues, while necrobiosis lipoidica is a granulomatous dermatosis.

C. Scleroderma (option C) is a connective tissue disease characterized by excessive fibrosis and hardening of the skin and internal organs, unlike necrobiosis lipoidica, which is limited to the skin.

D. Skin infections (option D) are unrelated to necrobiosis lipoidica, as necrobiosis lipoidica is a granulomatous dermatosis, while skin infections are caused by pathogens like bacteria, viruses, or fungi.

**Clinical Pearl:** Understanding the association between necrobiosis lipoidica and diabetes mellitus is crucial for proper diagnosis and management of this condition. In cases where necrobiosis lipoidica is suspected, a thorough assessment of the patient's medical history, particularly with regards to diabetes, should be performed to confirm the diagnosis.

**Correct Answer:** A. Diabetes mellitus

**Explanation:** Necrobiosis lipoidica is a rare dermatosis that primarily affects individuals with underlying diabetes mellitus, particularly those with poorly controlled diabetes. The condition may develop as a complication of diabetes, leading to skin changes that are indicative of the underlying systemic disease.